Liquid biopsy mutation panel for non-small cell lung cancer: analytical validation and clinical concordance

Molecular testing for genomic variants is recommended in advanced non-small cell lung cancer (NSCLC). Standard tissue biopsy is sometimes infeasible, procedurally risky, or insufficient in tumor tissue quantity. We present the analytical validation and concordance study of EGFR variants using a new...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartzberg, Lee S., Horinouchi, Hidehito, Chan, David, Chernilo, Sara, Tsai, Michaela L., Isla, Dolores, Escriu, Carles, Bennett, John P., Clark-Langone, Kim, Svedman, Christer, Tomasini, Pascale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314769/
https://www.ncbi.nlm.nih.gov/pubmed/32596507
http://dx.doi.org/10.1038/s41698-020-0118-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314769/
https://www.ncbi.nlm.nih.gov/pubmed/32596507
http://dx.doi.org/10.1038/s41698-020-0118-x

Ejemplares similares